![Dianthus Therapeutics Inc](/common/images/company/N_DNTH.png)
Dianthus Therapeutics Inc (DNTH)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -171.663 | -107.916 | -54.4 | -48.157 | -46.381 | -40.47 | -45.435 | -26.717 |
Return on Equity (%) | 219.405 | 139.265 | -111.278 | -53.527 | -52.568 | -44.941 | -54.884 | -31.696 |
Return on Invested Capital (%) | 208.88 | 140.117 | -117.868 | -58.577 | -55.908 | -47.724 | -58.823 | -35.436 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -1541.224 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -1541.224 |
Book Value Per Share | -2.547 | -6.932 | 4.373 | 3.578 | 2.965 | 2.937 | 1.747 | 11.396 |
Earnings Per Share | -2.794 | -5.844 | -1.73 | -1.945 | -1.544 | -1.21 | -1.261 | -2.939 |
Cash Per Share | 1.295 | 8.46 | 1.752 | 1.649 | 1.198 | 2.239 | 0.95 | 8.93 |
Working Capital Per Share | 2.449 | 7.959 | 4.051 | 3.439 | 2.887 | 2.888 | 1.666 | 11.325 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.191 |
EBIT Per Share | -2.707 | -5.841 | -1.727 | -1.945 | -1.544 | -1.21 | -1.261 | -2.939 |
EBITDA Per Share | -2.707 | -5.841 | -1.727 | -1.945 | -1.544 | -1.21 | -1.261 | -2.939 |
Free Cash Flow Per Share | -2.756 | -5.544 | -1.525 | -1.914 | -1.577 | -1.223 | -1.288 | -2.936 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 3,48M | 6,08M | 33,31M | 39,47M | 48,53M | 58,8M | 60,64M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 60,64M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -1572.998 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -1572.998 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 724,83M |
Ratio cours/bénéfice | -16,73 |
Ratio prix/ventes | 257,8 |
Ratio prix/liquidités | 5,51 |
Ratio prix/valeur comptable | 4,32 |
Rendement de dividende | - |
Actions en circulation | 29,6M |
Volume moyen (1 semaine) | 230,73k |
Volume moyen (1 mois) | 202,15k |
Variation sur 52 semaines | 2,33% |
Plus haut sur 52 semaines | 33,77 |
Plus bas sur 52 semaines | 18,345 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales